News tagged with 'Eprex'

Federal health officials are investigating a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug, Eprex, in a German study of stroke patients.

Just days after European health regulators announced they were considering a ban on use of the anemia drug Eprex in patients with chronic kidney failure due to its link to pure red cell aplasia (PRCA), Janssen-Cilag, a European subsidiary of Johnson & Johnson, said it will change the prescribing information of the medi

European health regulators are considering banning the use of the anemia drug Eprex in patients with chronic kidney failure due to an increasing number of reports that the medication may cause pure red cell aplasia (PRCA), a condition characterized by a near absence of red blood cell precursors that leaves many suffere

Johnson and Johnson announced Thursday that it has received 160 reports of pure red-cell aplasia (PRCA) among users of the anemia drug Eprex (erythropoietin). Eprex's link to PRCA, a condition characterized by a near absence of red blood cell precursors that leaves many patients dependent on transfusions to survive, h

Scientists are currently researching Mifeprex, also known as mifepristone, RU-486 or the "abortion pill," to see if the medication may be useful to treat a form of severe depression. A new report published in the journal Biological Psychiatry analyses a recent study that found Mifeprex to be highly effective in people

An antiabortion group is asking the U.S. Food and Drug Administration (FDA) to immediately ban the pregnancy medication Mifeprex, alleging the abortion pill causes adverse events. As part of the petition, Concerned Women for America, the American Association of Pro Life Obstetricians and Gynecologists and the Christia

Johnson & Johnson announced Thursday that it has received over 100 reports of pure red cell aplasia (PRCA) in patients taking the anemia drug Eprex (erythropoietin). The announcement comes one month after the U.S. Food and Drug Administration (FDA) officially confirmed the drug's link to the disorder in a letter publi

Officials with the U.S. Food and Drug Administration (FDA) officially confirmed the anemia drug Eprex's link to pure red cell aplasia (PRCA) in a letter published in this week's issue of The New England Journal of Medicine. Eprex's link to PRCA, a condition characterized by a near absence of red blood cell precursors,

Concerns over Johnson & Johnson's anti-anemia drug, Eprex, were renewed this week after a report in the New England Journal of Medicine confirmed that the medication is linked to a recent increase in pure red cell aplasia (PRCA) cases. PRCA is a condition characterized by a near absence of red blood cell precursors.

Johnson & Johnson's stock dropped two percent this week after the company announced that its anemia drug, Eprex, known in the U.S. as Procrit, may be linked to 40 confirmed cases of pure red cell aplasia (PRCA), a condition characterized by a near absence of red blood cell precursors. The company revealed that it